High tumor levels of VEGF reducing survival times in primary operable TNBC [192].Early predictor of pathological complete response to neoadjuvant chemotherapy and survival in TNBC patients and increased in T2DM patients [193,195]. This evidence concerns the gene VEGFA and neoplasm.